The Origins of the Doughnut Hole: Excess Profits on Prescription Drugs
This report shows that pharmaceutical companies are making billions in excess profits under the new Medicare drug benefit.
|Date of creation:||Aug 2006|
|Date of revision:|
|Contact details of provider:|| Postal: |
Phone: (202) 293-5380
Fax: (202) 588 1356
Web page: http://www.cepr.net/
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:epo:papers:2006-19. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ()
If references are entirely missing, you can add them using this form.